Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Butterfly Network, Inc.
SIC 3844 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Butterfly Network, Inc.
SIC 3844 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Butterfly Network, Inc.
SIC 3844 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Notes
Support
about
terms
$
BFLY
Butterfly Network, Inc.
CIK:
0001804176
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:
Total revenue
$ 32,612
$ 23,383
$ 59,142
$ 44,608
Cost of revenue:
Total cost of revenue
9,324
8,492
17,568
16,336
Gross profit
23,288
14,891
41,574
28,272
Operating expenses:
Research and development
10,542
8,315
20,080
18,239
Sales and marketing
11,467
11,559
22,884
23,179
General and administrative
11,355
9,130
22,173
18,729
Other
3,588
1,987
3,973
2,691
Total operating expenses
36,952
30,991
69,110
62,838
Loss from operations
(13,664)
(16,100)
(27,536)
(34,566)
Interest income
1,079
1,503
2,265
3,155
Interest expense
(282)
(368)
(561)
(715)
Change in fair value of warrant liabilities
0
620
413
1,446
Other income (expense), net
(43)
531
(168)
2,906
Loss before provision for income taxes
(12,910)
(13,814)
(25,587)
(27,774)
Provision for income taxes
0
20
0
27
Net loss
(12,910)
(13,834)
(25,587)
(27,801)
Comprehensive loss
$ (12,910)
$ (13,834)
$ (25,587)
$ (27,801)
Net loss per common share attributable to Class A and B common stockholders - basic (in dollars per share)
$ (0.05)
$ (0.06)
$ (0.10)
$ (0.12)
Net loss per common share attributable to Class A and B common stockholders - diluted (in dollars per share)
$ (0.05)
$ (0.06)
$ (0.10)
$ (0.12)
Weighted-average shares used to compute net loss per share attributable to Class A and B common stockholders - basic (in shares)
262,100,993
248,393,811
259,324,052
241,695,884
Weighted-average shares used to compute net loss per share attributable to Class A and B common stockholders - diluted (in shares)
262,100,993
248,393,811
259,324,052
241,695,884
Product
Revenue:
Total revenue
$ 15,720
$ 16,621
$ 30,373
$ 30,785
Cost of revenue:
Total cost of revenue
7,370
6,670
13,725
12,494
Software and other services
Revenue:
Total revenue
16,892
6,762
28,769
13,823
Cost of revenue:
Total cost of revenue
$ 1,954
$ 1,822
$ 3,843
$ 3,842
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:
Net loss
$ (25,587)
$ (27,801)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization, and impairments
3,471
4,442
Non-cash interest expense
561
713
Write-down of inventories
0
66
Stock-based compensation expense
12,580
12,148
Change in fair value of warrant liabilities
(413)
(1,446)
Other
834
172
Changes in operating assets and liabilities:
Accounts receivable
(8,636)
(3,909)
Inventories
2,830
1,816
Prepaid expenses and other assets
(9,630)
(874)
Vendor advances
46
1,244
Accounts payable
(1,945)
(927)
Deferred revenue
(10,643)
(581)
Change in operating lease assets and liabilities
(455)
(411)
Accrued expenses and other liabilities
6,824
(3,496)
Net cash used in operating activities
(30,163)
(18,844)
Cash flows from investing activities:
Purchases of property, equipment, and intangible assets, including capitalized software
(1,924)
(1,249)
Net cash used in investing activities
(1,924)
(1,249)
Cash flows from financing activities:
Proceeds from exercise of stock options
5,031
274
Proceeds from employee stock purchase plan
1,233
949
Net proceeds from share offering
0
81,006
Payments to tax authorities for restricted stock units withheld
(7)
(2,775)
Net cash provided by financing activities
6,257
79,454
Net increase (decrease) in cash, cash equivalents, and restricted cash
(25,830)
59,361
Cash, cash equivalents, and restricted cash, beginning of period
154,504
92,790
Cash, cash equivalents, and restricted cash, end of period
$ 128,674
$ 152,151
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:
Cash and cash equivalents
$ 124,659
$ 150,489
Accounts receivable, net of allowance for credit losses of $1,785 and $1,389 at June 30, 2026 and December 31, 2025, respectively
34,554
26,744
Inventories
58,559
61,389
Current portion of vendor advances
2,157
2,063
Prepaid expenses and other current assets
18,018
8,418
Total current assets
237,947
249,103
Property and equipment, net
15,850
16,587
Intangible assets, net
6,816
7,516
Non-current portion of vendor advances
4,868
5,008
Operating lease assets
11,805
12,652
Other non-current assets
5,709
5,667
Total assets
282,995
296,533
Current liabilities:
Accounts payable
3,518
5,442
Deferred revenue, current
15,472
26,909
Accrued purchase commitments, current
131
131
Warrant liabilities, current
0
413
Accrued expenses and other current liabilities
39,482
32,222
Total current liabilities
58,603
65,117
Deferred revenue, non-current
10,185
9,391
Operating lease liabilities
16,293
17,721
Other non-current liabilities
8,514
8,325
Total liabilities
93,595
100,554
Commitments and contingencies (Note 12)
Stockholders’ equity:
Additional paid-in capital
1,094,154
1,075,147
Accumulated deficit
(904,781)
(879,194)
Total stockholders’ equity
189,400
195,979
Total liabilities and stockholders’ equity
282,995
296,533
Class A Common Stock
Stockholders’ equity:
Common stock
24
23
Class B Common Stock
Stockholders’ equity:
Common stock
$ 3
$ 3